Literature DB >> 10715144

Dual function glutamate-related ligands: discovery of a novel, potent inhibitor of glutamate carboxypeptidase II possessing mGluR3 agonist activity.

F Nan1, T Bzdega, S Pshenichkin, J T Wroblewski, B Wroblewska, J H Neale, A P Kozikowski.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10715144     DOI： 10.1021/jm9905559

Source DB:  PubMed          Journal:  J Med Chem        ISSN： 0022-2623            Impact factor:   7.446


× No keyword cloud information.
  11 in total

1.  2-PMPA, a NAAG peptidase inhibitor, attenuates magnetic resonance BOLD signals in brain of anesthetized mice: evidence of a link between neuron NAAG release and hyperemia.

Authors:  Morris H Baslow; Victor V Dyakin; Karen L Nowak; Basalingappa L Hungund; David N Guilfoyle
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

2.  Local enema treatment to inhibit FOLH1/GCPII as a novel therapy for inflammatory bowel disease.

Authors:  Abhijit A Date; Rana Rais; Taarika Babu; Jairo Ortiz; Pranjali Kanvinde; Ajit G Thomas; Sarah C Zimmermann; Alexandra J Gadiano; Gilad Halpert; Barbara S Slusher; Laura M Ensign
Journal:  J Control Release       Date:  2017-01-31       Impact factor: 9.776

3.  N-acetylaspartylglutamate is an agonist at mGluR₃ in vivo and in vitro.

Authors:  Joseph H Neale
Journal:  J Neurochem       Date:  2011-12       Impact factor: 5.372

4.  Triazole Appending Agent (TAAG): A New Synthon for Preparing Iodine-Based Molecular Imaging and Radiotherapy Agents.

Authors:  Alla Darwish; Megan Blacker; Nancy Janzen; Stephanie M Rathmann; Shannon Czorny; Shawn M Hillier; John L Joyal; John W Babich; John F Valliant
Journal:  ACS Med Chem Lett       Date:  2012-02-18       Impact factor: 4.345

Review 5.  The therapeutic and diagnostic potential of the prostate specific membrane antigen/glutamate carboxypeptidase II (PSMA/GCPII) in cancer and neurological disease.

Authors:  James C Evans; Meenakshi Malhotra; John F Cryan; Caitriona M O'Driscoll
Journal:  Br J Pharmacol       Date:  2016-09-23       Impact factor: 8.739

6.  Borane Complexes of the H(3)PO(2) P(III) Tautomer: Useful Phosphinate Equivalents.

Authors:  Yamina Belabassi; Monika I Antczak; Jennifer Tellez; Jean-Luc Montchamp
Journal:  Tetrahedron       Date:  2008-09-22       Impact factor: 2.457

7.  Structural basis of interactions between human glutamate carboxypeptidase II and its substrate analogs.

Authors:  Cyril Barinka; Klara Hlouchova; Miroslava Rovenska; Pavel Majer; Miroslawa Dauter; Niyada Hin; Yao-Sen Ko; Takashi Tsukamoto; Barbara S Slusher; Jan Konvalinka; Jacek Lubkowski
Journal:  J Mol Biol       Date:  2008-01-05       Impact factor: 5.469

8.  Bioisosterism of urea-based GCPII inhibitors: Synthesis and structure-activity relationship studies.

Authors:  Haofan Wang; Youngjoo Byun; Cyril Barinka; Mrudula Pullambhatla; Hyo-Eun C Bhang; James J Fox; Jacek Lubkowski; Ronnie C Mease; Martin G Pomper
Journal:  Bioorg Med Chem Lett       Date:  2009-10-24       Impact factor: 2.823

9.  Synthesis and evaluation of technetium-99m- and rhenium-labeled inhibitors of the prostate-specific membrane antigen (PSMA).

Authors:  Sangeeta R Banerjee; Catherine A Foss; Mark Castanares; Ronnie C Mease; Youngjoo Byun; James J Fox; John Hilton; Shawn E Lupold; Alan P Kozikowski; Martin G Pomper
Journal:  J Med Chem       Date:  2008-07-19       Impact factor: 7.446

10.  Structural characterization of P1'-diversified urea-based inhibitors of glutamate carboxypeptidase II.

Authors:  Jiri Pavlicek; Jakub Ptacek; Jiri Cerny; Youngjoo Byun; Lubica Skultetyova; Martin G Pomper; Jacek Lubkowski; Cyril Barinka
Journal:  Bioorg Med Chem Lett       Date:  2014-03-28       Impact factor: 2.823
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.